Smith E, Frenkel B, Schlegel R, Giordano A, Lian J B, Stein J L, Stein G S
Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655, USA.
Cancer Res. 1995 Nov 1;55(21):5019-24.
The representation of cyclins and cyclin-dependent kinases (cdks) was analyzed during progressive development of the bone cell phenotype in cultures of normal diploid rat calvarial osteoblasts. Three developmental stages were examined: (a) proliferation; (b) monolayer confluency; and (c) mineralization of the bone extracellular matrix. We demonstrate that the presence of cyclins and cdks is not restricted to the proliferation period. Consistent with their role in cell cycle progression, cdc2 and cdk2 decrease postproliferatively. However, cdk4 and cyclins A, B, and D1 persist in confluent cells. Cyclin E is significantly up-regulated during the extracellular matrix mineralization developmental period. Examination of the cytoplasmic levels of these cell cycle regulatory proteins indicates a marked increase in cyclin B in the late differentiation stage. The elevation of nuclear cyclin E and cytoplasmic cyclin B is not observed in osteoblasts maintained under culture conditions that do not support differentiation. Furthermore, treatment with transforming growth factor beta for 48 h during the proliferation period renders the cells incompetent for differentiation and abrogates the postproliferative up-regulation of cyclins B and E. Density-induced growth inhibition of ROS 17/2.8 osteosarcoma cells is not accompanied by up-regulation of nuclear cyclin E and cytoplasmic cyclin B when compared to the proliferation period. This observation is consistent with abrogation of both growth control and differentiation regulatory mechanisms in tumor cells. These results suggest that cell cycle regulatory proteins function not only during proliferation but may also play a role in normal diploid osteoblast differentiation.
在正常二倍体大鼠颅骨成骨细胞培养物中,随着骨细胞表型的逐步发展,对细胞周期蛋白和细胞周期蛋白依赖性激酶(cdks)进行了分析。研究了三个发育阶段:(a)增殖;(b)单层汇合;(c)骨细胞外基质矿化。我们证明细胞周期蛋白和cdks的存在并不局限于增殖期。与它们在细胞周期进程中的作用一致,cdc2和cdk2在增殖后减少。然而,cdk4以及细胞周期蛋白A、B和D1在汇合细胞中持续存在。在细胞外基质矿化发育阶段,细胞周期蛋白E显著上调。对这些细胞周期调节蛋白的细胞质水平检测表明,在晚期分化阶段,细胞周期蛋白B显著增加。在不支持分化的培养条件下培养的成骨细胞中,未观察到细胞核细胞周期蛋白E和细胞质细胞周期蛋白B的升高。此外,在增殖期用转化生长因子β处理48小时,使细胞无法分化,并消除了细胞周期蛋白B和E在增殖后的上调。与增殖期相比,ROS 17/2.8骨肉瘤细胞密度诱导的生长抑制并未伴随着细胞核细胞周期蛋白E和细胞质细胞周期蛋白B的上调。这一观察结果与肿瘤细胞中生长控制和分化调节机制的丧失一致。这些结果表明,细胞周期调节蛋白不仅在增殖过程中发挥作用,而且可能在正常二倍体成骨细胞分化中发挥作用。